European Innovation Council

Right HeartWise is a medical device company that develops patient-specific implantable right heart pumps to support right-sided heart failure. The pumps are non-motorized and self-powered, with no batteries or external cables, and are fully customized to each patient's anatomy. By eliminating bulky components, the device aims to improve comfort and mobility, enabling an active lifestyle with a focus on safety and ease of use.

RespiQ is a healthtech company developing portable, non-invasive breath analysis technology that uses emission spectroscopy and artificial intelligence to detect biomarkers in breath for early identification and real-time monitoring of respiratory diseases such as COPD, as well as other conditions like asthma, lung cancer, and infectious diseases. Its device aims to be affordable and user-friendly, democratizing access to advanced diagnostics, while its platform can also identify digestive issues through breath biomarkers and support personalized guidance via an app that analyzes a digital breath print to deliver diet and health insights, enabling individuals to monitor changes and improve health outcomes.

VIVAN Therapeutics pioneers personalized cancer therapeutics using innovative assay technology. It licenses technology from the Center for Personalized Cancer Therapeutics at Mount Sinai New York, offering a comprehensive, genomics-based drug screening service enabled by blockchain. The company's approach intelligently designs personalized treatments, combining cancer and non-cancer drugs to reduce toxicity and cost.

Brainhero offers home-based neurofeedback therapy using EEG technology. It aims to help children manage symptoms of Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) through engaging, app-based brain training.

Vésale Pharma collaborates with renowned global research institutions to develop innovative healthcare solutions tailored for diverse populations. Their product portfolio spans dermatology, gastroenterology, women's health, immunity, and pregnancy, aiming to enhance overall well-being without adverse side effects.

Restore Medical develops a device-based therapy for congestive heart failure. Its product, ContraBand, is a catheter-delivered implant in the pulmonary arteries designed to improve patient quality of life and reduce hospital readmission rates.

NeuroKaire develops personalized psychiatry testing tools. It uses innovative technology to predict the most effective drug treatment for patients, enabling faster recovery, fewer side effects, and lower dosing.

Askel is a medical technology company specializing in knee cartilage repair. Its innovative device aims to enhance recovery, prevent osteoarthritis, reduce healthcare costs, and facilitate swift rehabilitation.

Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.

AVeta Medical develops hormone-free, safe, and affordable biotechnology medical devices for treating underlying conditions of vaginal atrophy. Their innovative solutions target symptoms and restore tissue health naturally, providing long-term benefits with easy-to-use treatments.

PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.

NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.

Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.

moveUP develops digital therapeutics solutions, focusing on improving patient engagement and streamlining healthcare delivery. Its closed-loop system ensures high compliance and better outcomes by continuously collecting data to personalize treatment. Currently, it offers a therapy for orthopaedic patients undergoing joint surgery, with CE medical device certification.

PKvitality is a French bio-wearable company founded in 2017. It specializes in developing non-invasive health monitoring devices, notably the K’Watch Glucose, a smartwatch that enables diabetic patients to monitor their glucose levels painlessly and discreetly.

Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.

Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

Weber Hospital Systems is a company that specializes in developing solutions to help minimize healthcare-associated infections (HAIs) in hospitals. By developing innovative solutions to help reduce the risk of HAIs, Weber Hospital Systems is likely to play an important role in improving patient outcomes and overall hospital safety. Their solutions include a range of products such as disinfectant systems, air filtration systems, and surface coatings that are designed to eliminate or reduce the presence of harmful pathogens in the hospital environment. One of the company's flagship products is the Weber Mediclean System, a fully automated disinfection system that uses UV-C light to kill bacteria and viruses on hospital surfaces. This system is designed to be fast and efficient, eliminating up to 99.99% of bacteria and viruses within a matter of minutes. In addition to their disinfection systems, Weber Hospital Systems also offers air filtration systems that use advanced HEPA filtration technology to remove harmful particles and pathogens from the air. Their surface coatings are designed to create a barrier that prevents the growth of bacteria and viruses on hospital surfaces, providing an additional layer of protection against HAIs.

Xsensio is a digital health company focused on revolutionizing healthcare monitoring. It specializes in developing a wearable, Lab-on-Skin© platform that continuously analyzes biochemical data from the skin's surface in real-time, offering unprecedented insights into health and wellness.

moveUP develops digital therapeutics solutions, focusing on improving patient engagement and streamlining healthcare delivery. Its closed-loop system ensures high compliance and better outcomes by continuously collecting data to personalize treatment. Currently, it offers a therapy for orthopaedic patients undergoing joint surgery, with CE medical device certification.

Picterus is developing an app to diagnose jaundice in newborns, aiming to reduce the global infant mortality associated with this condition. The platform uses a patented color calibration card and smartphone camera for accurate image capture, providing healthcare professionals and caregivers with a reliable tool for early detection and timely intervention.

Picterus is developing an app to diagnose jaundice in newborns, aiming to reduce the global infant mortality associated with this condition. The platform uses a patented color calibration card and smartphone camera for accurate image capture, providing healthcare professionals and caregivers with a reliable tool for early detection and timely intervention.

NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.

NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma. The company has created a nanosensor-based wearable device that enables the early detection of subtle changes in a patient's respiratory condition. By identifying these changes before they reach critical stages, NanoVation aims to improve patient outcomes through timely interventions and reduce the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation focuses on empowering healthcare professionals with the tools needed to monitor patients at home effectively, facilitating proactive measures in respiratory care.